A consensus molecular classification of muscle-invasive bladder cancer A Kamoun, A de Reynies, Y Allory, G Sjödahl, AG Robertson, R Seiler, ... European urology 77 (4), 420-433, 2020 | 1031 | 2020 |
A molecular taxonomy for urothelial carcinoma G Sjödahl, M Lauss, K Lövgren, G Chebil, S Gudjonsson, S Veerla, ... Clinical cancer research 18 (12), 3377-3386, 2012 | 926 | 2012 |
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ... European urology 72 (4), 544-554, 2017 | 790 | 2017 |
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome D Lindgren, A Frigyesi, S Gudjonsson, G Sjödahl, C Hallden, G Chebil, ... Cancer research 70 (9), 3463-3472, 2010 | 335 | 2010 |
Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification G Sjödahl, P Eriksson, F Liedberg, M Höglund The Journal of pathology 242 (1), 113-125, 2017 | 329 | 2017 |
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma D Lindgren, G Sjödahl, M Lauss, J Staaf, G Chebil, K Lövgren, ... PloS one 7 (6), e38863, 2012 | 226 | 2012 |
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer SV Lindskrog, F Prip, P Lamy, A Taber, CS Groeneveld, ... Nature communications 12 (1), 2301, 2021 | 216 | 2021 |
Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants JI Warrick, G Sjödahl, M Kaag, JD Raman, S Merrill, L Shuman, G Chen, ... European urology 75 (1), 18-22, 2019 | 208 | 2019 |
Toward a molecular pathologic classification of urothelial carcinoma G Sjödahl, K Lövgren, M Lauss, O Patschan, S Gudjonsson, G Chebil, ... The American journal of pathology 183 (3), 681-691, 2013 | 203 | 2013 |
A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort N Marzouka, P Eriksson, C Rovira, F Liedberg, G Sjödahl, M Höglund Scientific reports 8 (1), 3737, 2018 | 171 | 2018 |
A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1 G Sjödahl, M Lauss, S Gudjonsson, F Liedberg, C Halldén, G Chebil, ... PloS one 6 (4), e18583, 2011 | 150 | 2011 |
Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors G Sjödahl, K Lövgren, M Lauss, G Chebil, O Patschan, S Gudjonsson, ... Urologic Oncology: Seminars and Original Investigations 32 (6), 791-797, 2014 | 145 | 2014 |
A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma O Patschan, G Sjödahl, G Chebil, K Lövgren, M Lauss, S Gudjonsson, ... European urology 68 (5), 824-832, 2015 | 143 | 2015 |
Biological determinants of bladder cancer gene expression subtypes M Aine, P Eriksson, F Liedberg, G Sjödahl, M Höglund Scientific reports 5 (1), 10957, 2015 | 134 | 2015 |
Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypes G Sjödahl, J Abrahamsson, K Holmsten, C Bernardo, G Chebil, ... European urology 81 (5), 523-532, 2022 | 96 | 2022 |
Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems P Eriksson, M Aine, S Veerla, F Liedberg, G Sjödahl, M Höglund BMC medical genomics 8, 1-15, 2015 | 85 | 2015 |
Molecular profiling in muscle‐invasive bladder cancer: more than the sum of its parts G Sjödahl, CL Jackson, JMS Bartlett, DR Siemens, DM Berman The Journal of pathology 247 (5), 563-573, 2019 | 83 | 2019 |
On Molecular Classification of Bladder Cancer: Out of One, Many. M Aine, P Eriksson, F Liedberg, M Höglund, G Sjödahl European urology 68 (6), 921-923, 2015 | 68 | 2015 |
DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status. HM Lauss M, Aine M, Sjödahl G, Veerla S, Patschan O Epigenetics 7 (8), 858-867, 2012 | 57 | 2012 |
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma G Sjödahl, P Eriksson, O Patschan, NAD Marzouka, L Jakobsson, ... International Journal of Cancer 146 (9), 2636-2647, 2020 | 56 | 2020 |